Wockhardt Fact Sheet, Wockhardt Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Wockhardt Fact Sheet    (WOCK)

Here is the latest financial fact sheet of Wockhardt. For more details, see the Wockhardt quarterly results and Wockhardt share price and chart. For a sector overview, read our pharmaceuticals sector report.

WOCKHARDT Price History

Price Rs 303.1
Mkt Cap Rs m 33,353
Vol '000 175.9
P/E X -22.2
P/CF X -6.4
EPS (TTM) Rs -13.7
% ch % -1.2
No. of shares m 110.04
% ch week % -3.7
% ch 1-mth % 10.2
% ch 12-mth % -47.6
52 week H/L Rs 639.0/231.5
(As on Sep 20, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

WOCKHARDT Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
WOCKHARDT EQUITY SHARE DATA
High Rs2,0701,9802,0001,1291,012 
Low Rs337455706627532 
Sales per share (Unadj.) Rs440.1407.2403.0363.1355.9 
Earnings per share (Unadj.) Rs76.636.822.8-20.4-60.3 
Diluted earnings per shareRs76.436.822.9-20.5-60.6 
Cash flow per share (Unadj.) Rs89.450.035.7-7.0-46.8 
Dividends per share (Unadj.) Rs10.0020.00010.000.01 
Adj. dividends per shareRs9.9720.010.0010.050.01 
Dividend yield (eoy) %0.81.601.10 
Book value per share (Unadj.) Rs299.1335.1341.6301.8257.8 
Adj. book value per shareRs298.3335.2343.1303.2259.2 
Shares outstanding (eoy) m109.75110.07110.51110.55110.63 
Bonus/Rights/Conversions  ESOPESOP-IS- 
Price / Sales ratio x2.73.03.42.42.2 
Avg P/E ratio x15.733.159.3-42.9-12.8 
P/CF ratio (eoy) x13.524.337.9-125.9-16.5 
Price / Book Value ratio x4.03.64.02.93.0 
Dividend payout %13.154.40-48.90 
Avg Mkt Cap Rs m132,062133,983149,50997,06385,379 
No. of employees `0008.66.87.46.86.3 
Total wages/salary Rs m7,6868,6899,5089,6659,371 
Avg. sales/employee Rs Th5,616.76,557.76,037.25,931.86,295.0 
Avg. wages/employee Rs Th893.81,271.41,289.01,428.11,498.3 
Avg. net profit/employee Rs Th977.6592.5342.0-334.0-1,066.3 
WOCKHARDT INCOME DATA
Net Sales Rs m48,30444,81544,53040,14639,369 
Other income Rs m3846666611,1431,202 
Total revenues Rs m48,68845,48145,19141,28940,571 
Gross profit Rs m10,2577,0944,94212818 
Depreciation Rs m1,3991,4541,4191,4891,495 
Interest Rs m8345521,2902,2532,555 
Profit before tax Rs m8,4085,7532,895-2,472-2,830 
Minority Interest Rs m-21-78600 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m498000-3,582 
Tax Rs m4791,627379-211257 
Profit after tax Rs m8,4074,0492,522-2,260-6,669 
Gross profit margin %21.215.811.10.30 
Effective tax rate %5.728.313.18.5-9.1 
Net profit margin %17.49.05.7-5.6-16.9 
WOCKHARDT BALANCE SHEET DATA
Current assets Rs m33,55934,63739,51945,35333,796 
Current liabilities Rs m17,43217,75218,41919,78826,917 
Net working cap to sales %33.437.747.463.717.5 
Current ratio x1.92.02.12.31.3 
Inventory Days Days75839010179 
Debtors Days Days3653919489 
Net fixed assets Rs m30,02233,90937,36940,16539,664 
Share capital Rs m549550553553553 
"Free" reserves Rs m28,21936,33237,19932,81427,968 
Net worth Rs m32,82936,88337,75133,36728,522 
Long term debt Rs m11,02314,27019,20631,90321,731 
Total assets Rs m66,22071,71581,20990,21781,620 
Interest coverage x11.111.43.2-0.1-0.1 
Debt to equity ratio x0.30.40.51.00.8 
Sales to assets ratio x0.70.60.50.40.5 
Return on assets %14.06.44.70-5.0 
Return on equity %25.611.06.7-6.8-23.4 
Return on capital %22.212.27.4-0.3-7.7 
Exports to sales %12.810.011.600 
Imports to sales %7.86.24.500 
Exports (fob) Rs m6,1804,4715,17700 
Imports (cif) Rs m3,7602,7731,99000 
Fx inflow Rs m11,02610,7407,5899,1219,807 
Fx outflow Rs m4,3613,3562,8782,1331,789 
Net fx Rs m6,6657,3834,7116,9888,019 
WOCKHARDT CASH FLOW
From Operations Rs m 14,763 3,550 716 -2,695 684 
From Investments Rs m -8,516 -2,066 -8,182 -6,866 6,302 
From Financial Activity Rs m -6,013 -757 2,543 12,545 -7,695 
Net Cashflow Rs m 234 727 -4,941 3,007 -664 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 2.3%
FIIs 7.7%
ADR/GDR 0.1%
Free float 15.4%
Shareholders 67,757
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Wockhardt Towers, C/2-G Block, BKC, Bandra (E), Mumbai-400 051
E-MAIL investorrelations@wockhardt.com WEB www.wockhardt.com
TELEPHONE (022) 2653 4444 FAX (022) 2652 3905
SECTOR PHARMACEUTICALS GROUP KHORAKIWALA
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Haribhakti & Co.
CHM: Habil Khorakiwala COMP SEC: V. R. Khetan YEAR OF INC: 1973 BSE CODE: 532300 FV (Rs): 5 DIV YIELD (%): 0.0

More Pharmaceuticals Company Fact Sheets:   PANACEA BIOTECH  LUPIN  FDC LTD.  SANOFI INDIA  J.B.CHEMICALS  

Compare WOCKHARDT With:   PANACEA BIOTECH  LUPIN  FDC LTD.  SANOFI INDIA  J.B.CHEMICALS  

Compare WOCKHARDT With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Views on news

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India (The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market (The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On (Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown (The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted (Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT

WOCKHARDT - TEVA PHARMA COMPARISON

COMPARE WOCKHARDT WITH

MARKET STATS